The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions.

The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions.

Item
http://www.wikidata.org/entity/Q38235809
Safety issues and concerns of new immunomodulators in rheumatology.Clinical efficacy and safety of anti-IL-17 agents for the treatment of patients with psoriasis.Increased risk of herpes zoster in patients with psoriasis: A population-based retrospective cohort study.Progress in understanding and utilizing TNF-α inhibition for the treatment of psoriatic arthritis.Cutaneous side effects of TNF-alpha inhibitors.Nebenwirkungen von TNF-alpha-Inhibitoren am Hautorgan.Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo-controlled phase 3 trial.Varicella zoster virus meningitis under ustekinumab because of plaque psoriasis.Prevention of Herpes Zoster and its complications: From clinical evidence to real life experience.Herpes zoster in psoriasis patients undergoing treatment with biological agents: prevalence, impact, and management challenges.Assessment and monitoring of biologic drug adverse events in patients with psoriasis.
P2860

The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions.

Item
http://www.wikidata.org/entity/Q38235809
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The risk of herpes zoster duri ...... other inflammatory conditions.
@en
type
label
The risk of herpes zoster duri ...... other inflammatory conditions.
@en
prefLabel
The risk of herpes zoster duri ...... other inflammatory conditions.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
The risk of herpes zoster duri ...... other inflammatory conditions
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698